Cytology and Biomarkers in NMIBC
Cystoscopy and cytology remain the standard for diagnosis, but a plethora of urinary biomarkers could someday be a useful adjunct to NMIBC surveillance.
Bladder Cancer
FEATURES
Latest Bladder Cancer News
First Targeted Therapy for Metastatic Bladder Cancer Gets FDA Approval
Erdafitinib (brand name Balversa) is a fibroblast growth factor receptor (FGFR) kinase inhibitor.
Continued Smoking Among Cancer Patients Ups Costs by $3.4B
Estimates based on additional treatment following higher failure risk for first-line cancer treatment
New, Revised Topics Released in ACR Appropriateness Criteria
New topics relate to clinically suspected vascular malformation of extremities, gestational trophoblastic disease
Bladder Cancer Risk Elevated in Statin Users
In a large population-based study in Sweden, statin users had significant 31% increased odds of nonmuscle-invasive bladder cancer compared with nonusers.
CRPC Linked to Increased Risk for Second Primary Malignancies
Men with castration-resistant prostate cancer have an incidence rate of second primary malignancies 3-fold higher than the population-based cancer incidence among men without prostate cancer
Prostatic Urethral Involvement Tied to Worse Outcomes in NMIBC
According to researchers, PUI represents a high-risk pathologic feature of nonmuscle-invasive bladder cancer.
Bladder Cancer Linked to Early Menopause in Smokers
Among women with a history of smoking, menopause onset at age 45 or younger is associated with a 66% higher risk of bladder cancer compared with onset at age 50 or older.
Bladder Cancer Surgery Delay Increases Death Risk
Patients who undergo radical cystectomy for MIBC more than 12 weeks from diagnosis are at increased risk of death, regardless of whether they receive neoadjuvant chemotherapy.
Squamous MIBC Histology Predicts Worse Survival
Squamous cell carcinoma is associated with a 79% increased risk of death compared with urothelial carcinoma in patients with muscle-invasive bladder cancer, study finds.
Suicide Risk Up More Than 4-fold for Cancer Patients
Standardized mortality ratio highest for cancers of lung, head and neck, testes, bladder, Hodgkin lymphoma.
Want to read more?
Please login or register first to view this content.
Next post in Bladder Cancer
